ROG.SW

Equity

ROCHE GS

Health Care · Drug Manufacturers - General

$367.00

+367.00 (+0.00%)

Open

N/A

Day Range

$364.00 - $370.20

52W Range

$231.90 - $374.90

Volume

2M

Price History

Key Statistics

Market Cap

N/A

P/E Ratio

N/A

EPS

N/A

Dividend Yield

N/A

P/B Ratio

N/A

Payout Ratio

N/A

ROE

N/A

Debt/Equity

N/A

Latest News

PacBio, Myriad Genetics, LeMaitre, Hims & Hers Health, and GoodRx Shares Are Falling, What You Need To Know

StockStory 11 minutes ago

A Look At Laureate Education (LAUR) Valuation After Recent Share Price Pullback

Simply Wall St. 12 minutes ago

LA Metro's 'Ride the D' shirts sell out. We wonder why

USA TODAY 12 minutes ago

How Spire Global (SPIR) Story Is Shifting As Higher P/E Assumptions Reshape Valuation Expectations

Simply Wall St. 12 minutes ago

Assessing Compass (COMP) Valuation After Record Results And New Alliance With Rocket And Redfin

Simply Wall St. 12 minutes ago

Fair Value Estimate

DDM Value

$114.57

220.3% overvalued

Growth: 1.4% | Req. return: 10%

Community Sentiment

Sign in to vote

0% Bullish 0% Neutral 100% Bearish

0 votes

Discussion (0)

Sign in to join the discussion

Loading comments...

About ROCHE GS

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

www.roche.com →

Dividend Safety

Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.

60

Safe

Based on 4 fundamental factors

+ 9 years of growth

Analysis Tools

Sign in for analysis tools

Share